Go back to the public home page
Hello .
 U.S. 


  • News

    • International News

    • Education

    • Environment

    • Healthcare

    • Technology

      • Internet

    • Science

    • Social and Non-Profit

    • Local News

  • Politics
    and Policy

    • Government

    • Politics

    • Local Government

    • International Policy

  • Business
    and Economy

    • Economy

    • Finance

      • Stock Markets

    • Jobs and Labor

    • Company News

    • Industry News

      • Aerospace

      • Agriculture

      • Chemicals

      • Commodities

      • Construction and Engineering

      • Consumer Electronics

      • Defense

      • Energy

        • Nuclear Energy

        • Oil and Gas

        • Renewable Energy

      • Financial Services

        • Banking

        • Insurance

      • Fishing and Aquaculture

      • Manufacturing

      • Information Technology

      • Metals and Mining

      • Pharmaceuticals and Biotechnology

      • Real Estate

      • Professional and Business Services

        • Legal

      • Telecommunications

      • Tobacco

      • Retail

      • Transportation

        • Air Transportation

        • Maritime Transportation

        • Rail Transportation

        • Road Transportation

      • Utilities

      • Forestry and Wood Industry

  • Arts
    and Culture

    • Art

    • Books and Literature

    • Entertainment

      • Cinema

      • Media

        • Radio and Television

      • Music

  • Lifestyle
    and Leisure

    • Automotive

    • Home and Garden

    • Fashion and Luxury

      • Textile and Apparel

    • Food

    • Travel and Hospitality

    • Boating and Yachting


  • Sports

    • Baseball

    • Basketball

    • Boxing

    • Cricket

    • Cycling

    • Football (American)

    • Football (Australian)

    • Football (Soccer)

    • Golf

    • Hockey

    • Racing

    • Rugby

    • Sailing

    • Skiing and Winter Sports

    • Tennis

    • Volleyball

related announcements

News

  • Verve Therapeutics Inc.

    Verve Therapeutics Reports Durable and Well-Tolerated Editing of[...]

  • Verve Therapeutics Inc.

    Verve Therapeutics to Participate in Upcoming May Investor Conferences

  • Verve Therapeutics Inc.

    Verve Therapeutics Reports Additional VERVE-101 and GalNAc-Lipid[...]

More

Healthcare

  • Verve Therapeutics Inc.

    Verve Therapeutics Announces Clearance of First VERVE-101 Clinical[...]

  • Stem Cell Authority Ltd.

    Notification of Late Filing

  • Zymergen Inc.

    J.P. Morgan Presentation

More

Chembio Diagnostics Inc.

01/18/2022 | Press release | Distributed by Public on 01/18/2022 05:28

Initial Registration Statement for Employee Benefit Plan (Form S-8)

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

  • Newsvine
  • Digg
  • Delicious
  • StumbleUpon
  • Technorati
  • Buzz
  • Favorites
  • Google Reader

Please use the above public link if you want to share this noodl on another website.

Close

Smartlinks | Chembio Diagnostics Inc. | News | Crime and Judiciary | Judiciary | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Business Announcement | Public Share Offering | Professional and Business Services | Audit and Accounting Services | Legal Services | Judiciary | Public Companies | Pharmaceutical Companies | Börse Berlin | Börse Stuttgart | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago

 Back

Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact